title: Prostate-specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer.
authors.affiliation: Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
authors.forename: John A
authors.identifier: 0000-0002-6799-6039
authors.initials: JA
authors.lastname: Violet
authors.affiliation: Department of Nuclear Medicine and Molecular imaging, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Hofman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood / Q000528:radiation effects*; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D011868:Radioisotopes; D017430:Prostate-Specific Antigen